For Media
Connect With an Expert
BrightFocus Foundation’s in-house team of scientists are available for media interviews about Alzheimer’s disease, macular degeneration, and glaucoma. To arrange an interview, please contact Julia Roth at jroth@brightfocus.org.
Diane Bovenkamp, PhD, Vice President, Scientific Affairs
Diane Bovenkamp, PhD, Vice President of Scientific Affairs, is the chief scientist at BrightFocus Foundation, overseeing global operations of the organization’s research programs. She serves as the scientific liaison in local, national, and international forums, and identifies and develops new research initiatives, partnerships, and funding policies consistent with the mission of BrightFocus.
Dr. Bovenkamp obtained her PhD in biochemistry from Queen’s University in Kingston, Ontario, Canada, discovering and studying Eph receptors in angiogenesis and neural development in zebrafish and mice. She completed a postdoctoral fellowship in the Vascular Biology Program at Boston Children’s Hospital/Harvard Medical School, isolating and characterizing zebrafish neuropilins. Dr. Bovenkamp conducted further research at the Johns Hopkins University Bayview Proteomics Center in the Division of Cardiology at Johns Hopkins School of Medicine, using proteomic techniques for biomarker detection in human serum.
Sharyn Rossi, PhD, Senior Director of Neuroscience Programs
Dr. Sharyn Rossi received her PhD in anatomy and neurobiology from the University of California, Irvine, where she studied stem cell replacement therapies for the treatment of spinal cord injury. She continued her post-doctoral work at A.I. duPont Hospital for Children studying spinal muscular atrophy, and Johns Hopkins University, using optogenetics to investigate how transplanted stem cells integrate into brain circuitry after traumatic brain injury. Prior to joining BrightFocus, Dr. Rossi was a senior research scientist at the National Institute on Aging, using neuroimaging, light-sheet microscopy, and novel interventions to investigate changes in the brain during normal cognitive aging.
Latest Research News from BrightFocus-Funded Scientists
Breaking News Dispatch: New Findings on GLP-1 Drugs and Alzheimer’s, Novel Treatments in Development, and More
Get the latest news from the 2025 Clinical Trials on Alzheimer’s Disease (CTAD) conference.
4 Takeaways from Alzheimer’s Fast Track 2025
This innovative meeting hosted by BrightFocus Foundation bridges cutting-edge science, mentorship, and community building for early-career researchers.
Understanding Alzheimer’s & Exploring New Frontiers in Treatment
Watch a conversation inspired by the documentary film Taking Care and the latest research in Alzheimer’s therapies.
Shaping the Future of National Alzheimer’s Research Priorities
BrightFocus Foundation’s VP of Scientific Affairs helped set national research priorities at the federal Alzheimer’s Disease-Related Dementias Summit, influencing how billions in NIH funding will advance dementia research and care.
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
New Supplement to Prevent Macular Degeneration Inspires Deeper Search for Cures
A Macular Degeneration Research-funded scientist launched a supplement based on a link he discovered between the eye disease and Parkinson’s disease. Now he’s continuing research in the hopes of finding novel cures.
New Clues in the Fight Against Alzheimer’s: Q&A with Dr. Keith Hengen
During World Alzheimer’s Month, Alzheimer’s Disease Research grantee Dr. Keith Hengen joined BrightFocus’ Dr. Sharyn Rossi on Instagram Live to talk brain health—how the brain functions, why quality sleep matters, and tips to keep your brain healthy.
Protecting Vision: A New Approach to Scar-Free Healing From Glaucoma Surgery
BrightFocus National Glaucoma Research-funded scientist Jennifer Fan Gaskin, PhD, is exploring safer, more effective treatments to prevent scarring after glaucoma filtration surgery, also known as trabeculectomy.
2025 Annual Report Now Available
BrightFocus Foundation’s 2025 annual report celebrates groundbreaking research and public awareness.
Breaking News Dispatch: New Findings on GLP-1 Drugs and Alzheimer’s, Novel Treatments in Development, and More
Get the latest news from the 2025 Clinical Trials on Alzheimer’s Disease (CTAD) conference.
4 Takeaways from Alzheimer’s Fast Track 2025
This innovative meeting hosted by BrightFocus Foundation bridges cutting-edge science, mentorship, and community building for early-career researchers.
Understanding Alzheimer’s & Exploring New Frontiers in Treatment
Watch a conversation inspired by the documentary film Taking Care and the latest research in Alzheimer’s therapies.
Shaping the Future of National Alzheimer’s Research Priorities
BrightFocus Foundation’s VP of Scientific Affairs helped set national research priorities at the federal Alzheimer’s Disease-Related Dementias Summit, influencing how billions in NIH funding will advance dementia research and care.
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
New Supplement to Prevent Macular Degeneration Inspires Deeper Search for Cures
A Macular Degeneration Research-funded scientist launched a supplement based on a link he discovered between the eye disease and Parkinson’s disease. Now he’s continuing research in the hopes of finding novel cures.
New Clues in the Fight Against Alzheimer’s: Q&A with Dr. Keith Hengen
During World Alzheimer’s Month, Alzheimer’s Disease Research grantee Dr. Keith Hengen joined BrightFocus’ Dr. Sharyn Rossi on Instagram Live to talk brain health—how the brain functions, why quality sleep matters, and tips to keep your brain healthy.
Protecting Vision: A New Approach to Scar-Free Healing From Glaucoma Surgery
BrightFocus National Glaucoma Research-funded scientist Jennifer Fan Gaskin, PhD, is exploring safer, more effective treatments to prevent scarring after glaucoma filtration surgery, also known as trabeculectomy.
2025 Annual Report Now Available
BrightFocus Foundation’s 2025 annual report celebrates groundbreaking research and public awareness.
Fact Sheets
Alzheimer’s Disease Facts & Figures
Every three seconds, someone in the world develops dementia. That’s the same amount of time it takes to read this sentence out loud. Get the facts about Alzheimer’s disease—the most common form of dementia.
Macular Degeneration Facts & Figures
Advanced age-related macular degeneration (AMD) is a leading cause of irreversible blindness and visual impairment, affecting nearly 20 million U.S. adults who are living with some form of AMD.
Glaucoma Facts & Figures
More than three million Americans are living with glaucoma, a group of eye disorders that can lead to vision loss or complete blindness.
Press Releases
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
New Public Service Campaign Encourages Eye Exams to Save Sight
BrightFocus Foundation’s new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
BrightFocus Foundation and Focused Ultrasound Foundation Announce Partnership to Advance Alzheimer’s Research
A three-year collaboration supports pioneering non-invasive treatment strategies for Alzheimer’s disease using focused ultrasound.
BrightFocus and Alzheimer’s Los Angeles Renew Partnership to Fund Promising Alzheimer’s Research
Ongoing collaboration advances promising Alzheimer’s drug discovery research in Southern California.
BrightFocus Foundation Awards Nearly $13M to 50 Scientists for Alzheimer’s, Macular Degeneration, and Glaucoma Research
Private research nonprofit BrightFocus Foundation today announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation and Helen Keller Foundation Award University of Iowa Researchers 2025 Prize for Pioneering Eye Research
Drs. Val C. Sheffield and Edwin M. Stone of the University of Iowa have received the 2025 Helen Keller Prize for Vision Research for their groundbreaking work.
BrightFocus Foundation Recognizes Excellence in Vision Research
The annual BrightFocus Vision Research Awards honor outstanding scientists pursuing groundbreaking macular degeneration and glaucoma research.
BrightFocus Foundation Announces Appointment of Two New Board Members
BrightFocus Foundation, a leading nonprofit funder of innovative research to defeat Alzheimer’s disease, macular degeneration, and glaucoma, has appointed John S. Penn, PhD, a renowned vision scientist and professor at Vanderbilt University Medical Center, and Dale Young, chairman and CEO of Summit Financial Group, to its board of directors.
2024 Research Portfolios Now Available
BrightFocus proudly supports over 200 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
New Public Service Campaign Encourages Eye Exams to Save Sight
BrightFocus Foundation’s new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
BrightFocus Foundation and Focused Ultrasound Foundation Announce Partnership to Advance Alzheimer’s Research
A three-year collaboration supports pioneering non-invasive treatment strategies for Alzheimer’s disease using focused ultrasound.
BrightFocus and Alzheimer’s Los Angeles Renew Partnership to Fund Promising Alzheimer’s Research
Ongoing collaboration advances promising Alzheimer’s drug discovery research in Southern California.
BrightFocus Foundation Awards Nearly $13M to 50 Scientists for Alzheimer’s, Macular Degeneration, and Glaucoma Research
Private research nonprofit BrightFocus Foundation today announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation and Helen Keller Foundation Award University of Iowa Researchers 2025 Prize for Pioneering Eye Research
Drs. Val C. Sheffield and Edwin M. Stone of the University of Iowa have received the 2025 Helen Keller Prize for Vision Research for their groundbreaking work.
BrightFocus Foundation Recognizes Excellence in Vision Research
The annual BrightFocus Vision Research Awards honor outstanding scientists pursuing groundbreaking macular degeneration and glaucoma research.
BrightFocus Foundation Announces Appointment of Two New Board Members
BrightFocus Foundation, a leading nonprofit funder of innovative research to defeat Alzheimer’s disease, macular degeneration, and glaucoma, has appointed John S. Penn, PhD, a renowned vision scientist and professor at Vanderbilt University Medical Center, and Dale Young, chairman and CEO of Summit Financial Group, to its board of directors.
2024 Research Portfolios Now Available
BrightFocus proudly supports over 200 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.